{"gene":"DDX54","run_date":"2026-04-28T17:46:02","timeline":{"discoveries":[{"year":2002,"finding":"DDX54 (DP97), a DEAD-box RNA helicase, was identified as a novel nuclear receptor co-regulator that interacts with estrogen receptors (ER) and other nuclear receptors in a hormone-dependent manner and represses their transcriptional activity. Mapping studies localized the interaction to the C-terminal region of DP97 and the hormone-binding/AF-2 region of ERs. A small repression domain (aa 589–631) with homology to NCoR2/SMRTe was identified as necessary and sufficient for intrinsic repressor activity, while the N-terminal helicase region was dispensable for transcriptional repression. DDX54 possesses RNA-dependent ATPase activity. Knockdown of endogenous DDX54 by antisense or siRNA enhanced estradiol-ER-stimulated gene expression and attenuated ER-mediated repression.","method":"Co-immunoprecipitation, domain-mapping deletion studies, reporter assays, RNA-dependent ATPase activity assay, siRNA/antisense knockdown with gene expression readouts","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods (pulldown, mutagenesis/mapping, enzymatic assay, functional KD), moderate evidence","pmids":["12466272"],"is_preprint":false},{"year":2012,"finding":"DP97 (DDX54) was identified as a novel interacting protein of the constitutive androstane receptor (CAR) and acts as a gene-selective co-activator: siRNA knockdown of DP97 suppressed CAR-induced expression of CYP2B6 and UGT1A1 but not CYP3A4. DP97-mediated CAR transactivation was synergistically enhanced by co-expression of SRC-1 or PGC1α, suggesting DP97 acts as a mediator between CAR and co-activators.","method":"siRNA knockdown with mRNA expression readouts, co-expression/transactivation reporter assays in HepG2 cells","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 2-3 — functional KD with specific gene expression phenotype, single lab, moderate follow-up","pmids":["22910411"],"is_preprint":false},{"year":2011,"finding":"DDX54 (Ddx54) was identified as the antigen recognized by the 4F2 monoclonal antibody specific for oligodendrocyte lineage cells. Ddx54 was found to co-immunoprecipitate with all four isoforms of myelin basic protein (MBP) from brain homogenates and cultured oligodendrocyte cell lysates, indicating direct association. Co-transfection of Ddx54 with MBP isoform genes increased nuclear localization of the 21.5-kDa MBP isoform.","method":"Co-immunoprecipitation, immunohistochemistry, co-transfection localization assay","journal":"Journal of neuroscience research","confidence":"Medium","confidence_rationale":"Tier 2-3 — reciprocal Co-IP from brain tissue plus functional co-transfection localization assay, single lab","pmids":["21932369"],"is_preprint":false},{"year":2012,"finding":"Ddx54 knockdown in mouse brain (via intraventricular injection of Ad-shRNA:Ddx54 on postnatal day 2) caused defective myelination: MBP immunosignals accumulated in the subplate layer and failed to intrude into emerging white matter; the 21.5 kDa MBP isoform was specifically decreased while other MBP isoforms and oligodendrocyte markers were unchanged. Ddx54 transfection into neuroepithelial cells upregulated MBP promoter activity, and immunoprecipitation in HEK293 cells indicated Ddx54 directly interacts with MBP mRNA, suggesting a role in MBP mRNA metabolism and myelination.","method":"In vivo shRNA knockdown with immunohistochemistry/immunoblot, MBP promoter luciferase reporter assay, co-immunoprecipitation of Ddx54 with MBP mRNA","journal":"Journal of neuroscience research","confidence":"High","confidence_rationale":"Tier 2 — in vivo loss-of-function with specific myelination phenotype, multiple orthogonal methods, reporter assay and RNA-IP","pmids":["23239230"],"is_preprint":false},{"year":2017,"finding":"DDX54 is an immediate-to-early DNA damage response (DDR) regulator that is required for splicing efficacy of IR-induced pre-mRNAs. Upon ionizing radiation (IR), DDX54 increases its interaction with a defined class of pre-mRNAs harboring introns with weak acceptor splice sites, and forms protein-protein contacts with components of U2 snRNP and the spliceosomal B complex, resulting in reduced intron retention and higher processing rates of target transcripts. DDX54 promotes cell survival after IR exposure.","method":"Systematic interactome capture (UV crosslinking + poly(A) pulldown + MS), iCLIP, RNA-seq (splicing analysis), co-immunoprecipitation with spliceosomal components, siRNA knockdown with survival assays","journal":"Genome research","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods (interactome capture, iCLIP, Co-IP, functional KD), well-defined molecular mechanism","pmids":["28596291"],"is_preprint":false},{"year":2020,"finding":"DDX54 binds to the lncRNA SNHG10 and to PBX3 mRNA, and SNHG10 maintains PBX3 mRNA stability by recruiting DDX54, forming a regulatory feedback loop that promotes gastric cancer cell growth.","method":"RNA immunoprecipitation (RIP), RNA pulldown, siRNA knockdown, rescue overexpression assays","journal":"Digestive diseases and sciences","confidence":"Low","confidence_rationale":"Tier 3 — single lab, single Co-IP/pulldown approach, limited mechanistic follow-up","pmids":["32712782"],"is_preprint":false},{"year":2021,"finding":"DDX54 overexpression in colorectal cancer cells promotes proliferation and mobility by increasing phosphorylation of p65 and AKT, implicating DDX54 in activation of NF-κB and PI3K/AKT signaling pathways.","method":"siRNA knockdown and overexpression with phosphorylation analysis by western blot, proliferation/migration assays","journal":"Frontiers in oncology","confidence":"Low","confidence_rationale":"Tier 3 — single lab, signaling pathway placement via KD/OE with phosphorylation readout, no direct binding/mechanism established","pmids":["33968751"],"is_preprint":false},{"year":2021,"finding":"DDX54 protein is recruited by lncRNA PITPNA-AS1 and contributes to upregulation of SIK2 expression in triple-negative breast cancer cells, functioning downstream of PITPNA-AS1 sponging of miR-520d-5p.","method":"RNA pulldown, RIP assay, siRNA/overexpression rescue assays","journal":"Journal of translational medicine","confidence":"Low","confidence_rationale":"Tier 3 — single lab, RNA pulldown/RIP only, mechanistic placement largely inferred","pmids":["34353336"],"is_preprint":false},{"year":2022,"finding":"DDX54 is recruited by lncRNA CBR3-AS1 (which sponges miR-140-5p) to upregulate NUCKS1 expression, thereby activating the mTOR signaling pathway and promoting stemness and EMT in osteosarcoma cells.","method":"RIP, RNA pulldown, luciferase reporter, siRNA knockdown, rescue assays, in vivo xenograft","journal":"Molecular therapy oncolytics","confidence":"Low","confidence_rationale":"Tier 3 — single lab, mechanistic pathway placement relies on indirect evidence from lncRNA sponging model","pmids":["35592388"],"is_preprint":false},{"year":2023,"finding":"Oligodendrocyte-specific conditional knockout of Ddx54 (MBP-Cre driven) in mice, after completion of normal postnatal myelination, leads to progressive inner myelin sheath breakdown, loss of myelinated axons, oligodendrocyte apoptosis, glial activation, and death within 7 months, demonstrating that Ddx54 is indispensable for adult myelin homeostasis. Ddx54 knockdown also greatly impairs myelination in vitro, and Ddx54 expression is decreased in corpus callosum of MS patients.","method":"Conditional knockout mouse model (Ddx54 fl/fl;MBP-Cre), behavioral/histological/immunohistochemical analysis, in vitro myelination knockdown assay, human MS tissue analysis","journal":"iScience","confidence":"High","confidence_rationale":"Tier 2 — conditional in vivo KO with specific and well-characterized phenotypic readouts, replicated in vitro","pmids":["37720086"],"is_preprint":false},{"year":2025,"finding":"DDX54 inhibits the type I interferon antiviral response by facilitating m6A demethylation of selected transcripts including mavs mRNA via ALKBH5. Upon VSV infection, DDX54 relocalizes from the nucleolus to the nucleoplasm, where it and ALKBH5 independently bind m6A-modified transcripts forming m6A RNA/protein complexes. DDX54 interaction with ALKBH5 on these selected transcripts promotes ALKBH5 demethylase enzymatic activity (which is otherwise impaired during VSV infection), causing nuclear retention of demethylated transcripts and limiting their cytoplasmic translation, thereby impairing interferon signaling. ATPase activity of DDX54 is required both for binding selected transcripts and for promoting ALKBH5 activity. ALKBH5 knockout abrogated DDX54's suppressive effect on interferon response.","method":"VSV infection model, DDX54 overexpression/knockout/knockdown, ALKBH5 knockout, m6A-seq, RIP, subcellular fractionation/relocalization imaging, ATPase activity mutant analysis, interferon response assays","journal":"Journal of virology","confidence":"High","confidence_rationale":"Tier 1-2 — multiple orthogonal methods including enzymatic assays, mutagenesis, m6A-seq, genetic epistasis (ALKBH5 KO), functional relocalization, single but highly rigorous study","pmids":["40793791"],"is_preprint":false}],"current_model":"DDX54 is a nucleolar DEAD-box RNA helicase with RNA-dependent ATPase activity that functions as a nuclear receptor co-regulator (repressing ER and co-activating CAR in a gene-selective manner), an immediate-to-early DNA damage response splicing regulator (promoting U2 snRNP/spliceosomal B complex interactions to reduce intron retention at weak splice sites upon ionizing radiation), an essential factor for oligodendrocyte myelination and adult myelin homeostasis (via binding MBP mRNA and protein), and a negative regulator of antiviral innate immunity (by relocating from nucleolus to nucleoplasm upon VSV infection to recruit and stimulate the m6A eraser ALKBH5 on selected transcripts including mavs mRNA, thereby limiting their translation)."},"narrative":{"teleology":[{"year":2002,"claim":"The discovery that DDX54 possesses RNA-dependent ATPase activity and functions as a hormone-dependent co-repressor of estrogen receptors—through a discrete C-terminal repression domain—established it as the first DEAD-box helicase directly engaged in nuclear receptor transcriptional regulation.","evidence":"Co-immunoprecipitation, domain-mapping deletions, reporter assays, ATPase assay, and siRNA/antisense knockdown in human cells","pmids":["12466272"],"confidence":"High","gaps":["Whether helicase/ATPase activity contributes to transcriptional co-repression is unknown","No structural information for the repression domain or the ER interaction interface","Genome-wide set of ER target genes affected by DDX54 not defined"]},{"year":2011,"claim":"Identification of DDX54 as an oligodendrocyte-lineage protein that physically associates with all four MBP isoforms and influences the nuclear localization of the 21.5-kDa MBP isoform opened a new functional context—myelination—for this helicase.","evidence":"Co-immunoprecipitation from brain tissue and cultured oligodendrocytes, co-transfection localization assay","pmids":["21932369"],"confidence":"Medium","gaps":["Whether the DDX54–MBP interaction is direct or mediated by RNA was not resolved","Functional consequence for myelin formation not yet tested in vivo"]},{"year":2012,"claim":"In vivo knockdown of Ddx54 in neonatal mouse brain demonstrated that it is required for proper MBP mRNA metabolism and developmental myelination, with DDX54 binding MBP mRNA directly and regulating MBP promoter activity, while its role as a gene-selective CAR co-activator expanded its nuclear-receptor regulatory repertoire.","evidence":"Intraventricular Ad-shRNA injection with immunohistochemistry/immunoblot; RNA-IP; MBP promoter reporter; siRNA in HepG2 cells for CAR target genes","pmids":["23239230","22910411"],"confidence":"High","gaps":["Specific RNA motifs on MBP mRNA bound by DDX54 not mapped","Whether CAR co-activation requires DDX54 ATPase activity is untested","Whether DDX54 controls MBP mRNA transport, stability, or translation is unclear"]},{"year":2017,"claim":"Systematic interactome and iCLIP analysis revealed DDX54 as an immediate-to-early DNA damage response splicing regulator: upon ionizing radiation it increases binding to pre-mRNAs with weak acceptor splice sites and engages U2 snRNP/B complex components, reducing intron retention and promoting cell survival, thereby establishing a direct mechanistic link between DDX54 helicase activity and spliceosomal function.","evidence":"UV crosslinking poly(A) pulldown-MS, iCLIP, RNA-seq splicing analysis, co-IP with spliceosomal components, siRNA survival assays","pmids":["28596291"],"confidence":"High","gaps":["Whether ATPase/helicase activity is catalytically required for U2 snRNP recruitment was not tested","Upstream signal linking IR to increased DDX54–RNA binding unknown","Overlap between DDX54 splicing targets and its nuclear receptor target genes not explored"]},{"year":2023,"claim":"Oligodendrocyte-specific conditional knockout after developmental myelination proved DDX54 is indispensable for adult myelin homeostasis: loss causes progressive inner sheath breakdown, oligodendrocyte apoptosis, neuroinflammation, and death within months, and DDX54 expression is reduced in MS patient corpus callosum.","evidence":"Ddx54 fl/fl;MBP-Cre conditional KO mouse with behavioral, histological, and immunohistochemical characterization; in vitro myelination assay; human MS tissue analysis","pmids":["37720086"],"confidence":"High","gaps":["The molecular targets of DDX54 in mature oligodendrocytes (specific mRNAs or splicing events) are not defined","Whether DDX54 loss phenocopies MBP loss or involves additional substrates is unknown","Causal role of DDX54 reduction in MS pathogenesis not established"]},{"year":2025,"claim":"During viral infection, DDX54 relocalizes from the nucleolus to the nucleoplasm and uses its ATPase activity to bind m6A-modified transcripts and recruit/stimulate the m6A demethylase ALKBH5, causing nuclear retention of demethylated transcripts (including mavs) and suppressing type I interferon signaling—revealing an epitranscriptomic mechanism for DDX54-mediated immune regulation.","evidence":"VSV infection model, DDX54 OE/KO/KD, ALKBH5 KO epistasis, m6A-seq, RIP, subcellular fractionation/imaging, ATPase mutant analysis, interferon response assays","pmids":["40793791"],"confidence":"High","gaps":["How viral infection triggers DDX54 nucleolar-to-nucleoplasm relocalization is unknown","Whether DDX54–ALKBH5 cooperation extends to other viral infections beyond VSV is untested","Structural basis for DDX54 stimulation of ALKBH5 enzymatic activity not determined"]},{"year":null,"claim":"A unifying structural and regulatory framework—explaining how DDX54 ATPase/helicase activity is directed toward distinct substrate classes (nuclear receptor complexes, spliceosomal intermediates, MBP mRNA, m6A-modified transcripts) and how these functions are coordinated or segregated in different cellular contexts—remains to be established.","evidence":"","pmids":[],"confidence":"Low","gaps":["No high-resolution structure of DDX54 or its complexes exists","Context-dependent regulatory inputs (post-translational modifications, relocalization signals) are largely uncharacterized","Genome-wide catalog of direct DDX54 RNA targets across physiological contexts is incomplete"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0003723","term_label":"RNA binding","supporting_discovery_ids":[0,3,4,5,10]},{"term_id":"GO:0140657","term_label":"ATP-dependent activity","supporting_discovery_ids":[0,10]},{"term_id":"GO:0140098","term_label":"catalytic activity, acting on RNA","supporting_discovery_ids":[4,10]},{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[0,1]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[10]}],"localization":[{"term_id":"GO:0005730","term_label":"nucleolus","supporting_discovery_ids":[10]},{"term_id":"GO:0005654","term_label":"nucleoplasm","supporting_discovery_ids":[4,10]},{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[0,3,4,10]}],"pathway":[{"term_id":"R-HSA-8953854","term_label":"Metabolism of RNA","supporting_discovery_ids":[4,10]},{"term_id":"R-HSA-73894","term_label":"DNA Repair","supporting_discovery_ids":[4]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[10]},{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[0,1]}],"complexes":["spliceosomal B complex (functional interaction)"],"partners":["ESR1","NR1I3","MBP","ALKBH5","SNRNP200","PBX3"],"other_free_text":[]},"mechanistic_narrative":"DDX54 is a nucleolar DEAD-box RNA helicase with RNA-dependent ATPase activity that functions at the intersection of transcriptional co-regulation, pre-mRNA splicing, myelination, and innate immune modulation. It acts as a nuclear receptor co-regulator—repressing estrogen receptor-mediated transcription through a discrete repression domain homologous to NCoR2/SMRT [PMID:12466272] and gene-selectively co-activating the constitutive androstane receptor [PMID:22910411]—and as a DNA damage–responsive splicing factor that promotes U2 snRNP and spliceosomal B complex interactions to reduce intron retention at weak splice sites after ionizing radiation, thereby supporting cell survival [PMID:28596291]. DDX54 is essential for both developmental myelination and adult myelin homeostasis: it binds MBP mRNA and protein, and oligodendrocyte-specific conditional knockout causes progressive myelin breakdown, oligodendrocyte apoptosis, and lethality [PMID:23239230, PMID:37720086]. Upon viral infection, DDX54 relocalizes from the nucleolus to the nucleoplasm, where its ATPase activity is required to recruit and stimulate the m6A demethylase ALKBH5 on selected transcripts including mavs mRNA, promoting their nuclear retention and thereby suppressing type I interferon signaling [PMID:40793791]."},"prefetch_data":{"uniprot":{"accession":"Q8TDD1","full_name":"ATP-dependent RNA helicase DDX54","aliases":["ATP-dependent RNA helicase DP97","DEAD box RNA helicase 97 kDa","DEAD box protein 54"],"length_aa":881,"mass_kda":98.6,"function":"Nucleolar RNA helicase that is involved in diverse cellular processes including ribosome biogenesis, DNA damage response, RNA splicing, transcriptional regulation, innate immunity, and nervous system development. Plays an essential role in the formation of the ribosome active site by remodeling rRNA structure and initiating peptidyl transferase center formation (PubMed:38632236). Represses the transcriptional activity of several nuclear receptors. Regulates transcriptome dynamics during DNA damage response. Mechanistically, acts via increased interaction with a well-defined class of pre-mRNAs that contain introns with weak acceptor splice sites, as well as by protein-protein contacts within components of U2 snRNP and spliceosomal B complex. These activities lead to reduced intron retention and enhanced processing rates of its target transcripts (PubMed:28596291). Acts as an inhibitor of type I interferon antiviral response by facilitating ALKBH5-mediated demethylation of specific transcripts (PubMed:40793791). Contributes to central nervous system myelination, likely through regulation of oligodendrocyte differentiation and myelin sheath formation (By similarity)","subcellular_location":"Nucleus, nucleolus; Nucleus, nucleoplasm","url":"https://www.uniprot.org/uniprotkb/Q8TDD1/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":true,"resolved_as":"","url":"https://depmap.org/portal/gene/DDX54","classification":"Common Essential","n_dependent_lines":1203,"n_total_lines":1208,"dependency_fraction":0.9958609271523179},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[{"gene":"CSNK2B","stoichiometry":0.2},{"gene":"DRG1","stoichiometry":0.2},{"gene":"NPM1","stoichiometry":0.2},{"gene":"RACK1","stoichiometry":0.2},{"gene":"SRP19","stoichiometry":0.2},{"gene":"SRP68","stoichiometry":0.2},{"gene":"SRP9","stoichiometry":0.2},{"gene":"TPT1","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/search/DDX54","total_profiled":1310},"omim":[{"mim_id":"611665","title":"DEAD-BOX HELICASE 54; DDX54","url":"https://www.omim.org/entry/611665"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Nucleoplasm","reliability":"Approved"},{"location":"Nucleoli","reliability":"Approved"},{"location":"Golgi apparatus","reliability":"Approved"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/DDX54"},"hgnc":{"alias_symbol":["MGC2835","APR-5","DP97"],"prev_symbol":[]},"alphafold":{"accession":"Q8TDD1","domains":[{"cath_id":"3.40.50.300","chopping":"101-301","consensus_level":"high","plddt":89.8908,"start":101,"end":301},{"cath_id":"3.40.50.300","chopping":"312-559","consensus_level":"high","plddt":86.2698,"start":312,"end":559}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q8TDD1","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q8TDD1-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q8TDD1-F1-predicted_aligned_error_v6.png","plddt_mean":70.44},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=DDX54","jax_strain_url":"https://www.jax.org/strain/search?query=DDX54"},"sequence":{"accession":"Q8TDD1","fasta_url":"https://rest.uniprot.org/uniprotkb/Q8TDD1.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q8TDD1/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q8TDD1"}},"corpus_meta":[{"pmid":"12466272","id":"PMC_12466272","title":"Regulation of nuclear receptor transcriptional activity by a novel DEAD box RNA helicase (DP97).","date":"2002","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12466272","citation_count":56,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28596291","id":"PMC_28596291","title":"DDX54 regulates transcriptome dynamics during DNA damage response.","date":"2017","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/28596291","citation_count":44,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32712782","id":"PMC_32712782","title":"SNHG10/DDX54/PBX3 Feedback Loop Contributes to Gastric Cancer Cell Growth.","date":"2020","source":"Digestive diseases and sciences","url":"https://pubmed.ncbi.nlm.nih.gov/32712782","citation_count":25,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33968751","id":"PMC_33968751","title":"DDX54 Plays a Cancerous Role Through Activating P65 and AKT Signaling Pathway in Colorectal Cancer.","date":"2021","source":"Frontiers in oncology","url":"https://pubmed.ncbi.nlm.nih.gov/33968751","citation_count":20,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23239230","id":"PMC_23239230","title":"A DEAD-box RNA helicase Ddx54 protein in oligodendrocytes is indispensable for myelination in the central nervous system.","date":"2012","source":"Journal of neuroscience research","url":"https://pubmed.ncbi.nlm.nih.gov/23239230","citation_count":18,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34353336","id":"PMC_34353336","title":"MYBL2-induced PITPNA-AS1 upregulates SIK2 to exert oncogenic function in triple-negative breast cancer through miR-520d-5p and DDX54.","date":"2021","source":"Journal of translational medicine","url":"https://pubmed.ncbi.nlm.nih.gov/34353336","citation_count":17,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35592388","id":"PMC_35592388","title":"LncRNA CBR3-AS1 promotes osteosarcoma progression through the network of miR-140-5p/DDX54-NUCKS1-mTOR signaling pathway.","date":"2022","source":"Molecular therapy oncolytics","url":"https://pubmed.ncbi.nlm.nih.gov/35592388","citation_count":15,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22910411","id":"PMC_22910411","title":"DP97, a DEAD box DNA/RNA helicase, is a target gene-selective co-regulator of the constitutive androstane receptor.","date":"2012","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/22910411","citation_count":11,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21932369","id":"PMC_21932369","title":"A new monoclonal antibody, 4F2, specific for the oligodendroglial cell lineage, recognizes ATP-dependent RNA helicase Ddx54: possible association with myelin basic protein.","date":"2011","source":"Journal of neuroscience research","url":"https://pubmed.ncbi.nlm.nih.gov/21932369","citation_count":10,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"37720086","id":"PMC_37720086","title":"Lethal adulthood myelin breakdown by oligodendrocyte-specific Ddx54 knockout.","date":"2023","source":"iScience","url":"https://pubmed.ncbi.nlm.nih.gov/37720086","citation_count":4,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"40793791","id":"PMC_40793791","title":"DDX54 drives ALKBH5-mediated demethylation of selected transcripts to suppress interferon antiviral response.","date":"2025","source":"Journal of virology","url":"https://pubmed.ncbi.nlm.nih.gov/40793791","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"40172969","id":"PMC_40172969","title":"DDX54 downregulation enhances anti-PD1 therapy in immune-desert lung tumors with high tumor mutational burden.","date":"2025","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/40172969","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":null,"id":"bio_10.1101_2024.05.08.592371","title":"Activation of PKR by a short-hairpin RNA","date":"2024-05-10","source":"bioRxiv","url":"https://doi.org/10.1101/2024.05.08.592371","citation_count":0,"is_preprint":true,"source_track":"pubmed_title"},{"pmid":"17081983","id":"PMC_17081983","title":"Global, in vivo, and site-specific phosphorylation dynamics in signaling networks.","date":"2006","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/17081983","citation_count":2861,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"22658674","id":"PMC_22658674","title":"Insights into RNA biology from an atlas of mammalian mRNA-binding proteins.","date":"2012","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/22658674","citation_count":1718,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12477932","id":"PMC_12477932","title":"Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.","date":"2002","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/12477932","citation_count":1479,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26186194","id":"PMC_26186194","title":"The BioPlex Network: A Systematic Exploration of the Human Interactome.","date":"2015","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/26186194","citation_count":1118,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"28514442","id":"PMC_28514442","title":"Architecture of the human interactome defines protein communities and disease networks.","date":"2017","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/28514442","citation_count":1085,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26496610","id":"PMC_26496610","title":"A human interactome in three quantitative dimensions organized by stoichiometries and abundances.","date":"2015","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/26496610","citation_count":1015,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"22681889","id":"PMC_22681889","title":"The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts.","date":"2012","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/22681889","citation_count":973,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15635413","id":"PMC_15635413","title":"Nucleolar proteome dynamics.","date":"2005","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/15635413","citation_count":934,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"32296183","id":"PMC_32296183","title":"A reference map of the human binary protein interactome.","date":"2020","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/32296183","citation_count":849,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"11790298","id":"PMC_11790298","title":"Directed proteomic analysis of the human nucleolus.","date":"2002","source":"Current biology : CB","url":"https://pubmed.ncbi.nlm.nih.gov/11790298","citation_count":780,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"17353931","id":"PMC_17353931","title":"Large-scale mapping of human protein-protein interactions by mass spectrometry.","date":"2007","source":"Molecular systems biology","url":"https://pubmed.ncbi.nlm.nih.gov/17353931","citation_count":733,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"33961781","id":"PMC_33961781","title":"Dual proteome-scale networks reveal cell-specific remodeling of the human interactome.","date":"2021","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/33961781","citation_count":705,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21873635","id":"PMC_21873635","title":"Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium.","date":"2011","source":"Briefings in bioinformatics","url":"https://pubmed.ncbi.nlm.nih.gov/21873635","citation_count":656,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"29395067","id":"PMC_29395067","title":"High-Density Proximity Mapping Reveals the Subcellular Organization of mRNA-Associated Granules and Bodies.","date":"2018","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/29395067","citation_count":580,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15489334","id":"PMC_15489334","title":"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).","date":"2004","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/15489334","citation_count":438,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26638075","id":"PMC_26638075","title":"A Dynamic Protein Interaction Landscape of the Human Centrosome-Cilium Interface.","date":"2015","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/26638075","citation_count":433,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"35271311","id":"PMC_35271311","title":"OpenCell: Endogenous tagging for the cartography of human cellular organization.","date":"2022","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/35271311","citation_count":432,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26344197","id":"PMC_26344197","title":"Panorama of ancient metazoan macromolecular complexes.","date":"2015","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/26344197","citation_count":407,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12429849","id":"PMC_12429849","title":"Functional proteomic analysis of human nucleolus.","date":"2002","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/12429849","citation_count":391,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"34079125","id":"PMC_34079125","title":"A proximity-dependent biotinylation map of a human cell.","date":"2021","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/34079125","citation_count":339,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26949251","id":"PMC_26949251","title":"The cell proliferation antigen Ki-67 organises heterochromatin.","date":"2016","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/26949251","citation_count":265,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"27705803","id":"PMC_27705803","title":"A High-Density Map for Navigating the Human Polycomb Complexome.","date":"2016","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/27705803","citation_count":216,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21988832","id":"PMC_21988832","title":"Toward an understanding of the protein interaction network of the human liver.","date":"2011","source":"Molecular systems biology","url":"https://pubmed.ncbi.nlm.nih.gov/21988832","citation_count":207,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"29568061","id":"PMC_29568061","title":"An AP-MS- and BioID-compatible MAC-tag enables comprehensive mapping of protein interactions and subcellular localizations.","date":"2018","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/29568061","citation_count":201,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"18954305","id":"PMC_18954305","title":"Structural basis and specificity of human otubain 1-mediated deubiquitination.","date":"2009","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/18954305","citation_count":176,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"23602568","id":"PMC_23602568","title":"The protein interaction landscape of the human CMGC kinase group.","date":"2013","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/23602568","citation_count":174,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"32807901","id":"PMC_32807901","title":"UFMylation maintains tumour suppressor p53 stability by antagonizing its ubiquitination.","date":"2020","source":"Nature cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/32807901","citation_count":168,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"30804502","id":"PMC_30804502","title":"H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.","date":"2019","source":"Nature cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/30804502","citation_count":162,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"30833792","id":"PMC_30833792","title":"A protein-interaction network of interferon-stimulated genes extends the innate immune system landscape.","date":"2019","source":"Nature immunology","url":"https://pubmed.ncbi.nlm.nih.gov/30833792","citation_count":159,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"28973437","id":"PMC_28973437","title":"Quantitative proteomics reveals that long non-coding RNA MALAT1 interacts with DBC1 to regulate p53 acetylation.","date":"2017","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/28973437","citation_count":148,"is_preprint":false,"source_track":"gene2pubmed"}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":7857,"output_tokens":2494,"usd":0.030491},"stage2":{"model":"claude-opus-4-6","input_tokens":5807,"output_tokens":2427,"usd":0.134565},"total_usd":0.460607,"stage1_batch_id":"msgbatch_0118RScg3WGaGkaZRtWZbtce","stage2_batch_id":"msgbatch_01Cpfzvtbj42aqp5oYZ5Te2s","note":"batch pricing = 50% of standard","round2_stage1":{"model":"claude-sonnet-4-6","input_tokens":19504,"output_tokens":3206,"usd":0.053301},"round2_rules_fired":"R3","round2_stage2":{"model":"claude-opus-4-6","input_tokens":6780,"output_tokens":5104,"usd":0.24225}},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2002,\n      \"finding\": \"DDX54 (DP97) interacts in a hormone-dependent manner with nuclear receptors (estrogen receptors and others) through its C-terminal region binding to the hormone binding/activation function-2 region, and represses their transcriptional activity via a small repression domain (amino acids 589-631) homologous to NCoR2/SMRTe; knockdown by antisense or siRNA enhanced estradiol-ER-stimulated gene expression, confirming endogenous DDX54 dampens ER transcriptional activity. DDX54 also possesses RNA-dependent ATPase activity.\",\n      \"method\": \"Co-immunoprecipitation, domain mapping, reporter assay, antisense/siRNA knockdown, in vitro ATPase assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — multiple orthogonal methods (biochemical mapping, ATPase assay, functional knockdown) in a single study with rigorous controls\",\n      \"pmids\": [\"12466272\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"DP97 (DDX54) is a gene-selective co-activator for the constitutive androstane receptor (CAR): knockdown suppressed CAR-induced CYP2B6 and UGT1A1 but not CYP3A4 mRNA expression, and CAR transactivation was synergistically enhanced by co-expression of SRC-1 or PGC1α, suggesting DDX54 mediates between CAR and co-activators.\",\n      \"method\": \"siRNA knockdown, reporter/transactivation assay, co-expression experiments in HepG2 cells\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — clean KD with defined transcriptional phenotype, single lab\",\n      \"pmids\": [\"22910411\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Ddx54 co-immunoprecipitates with all four isoforms of myelin basic protein (MBP) in brain homogenates and oligodendrocyte lysates, and co-transfection of Ddx54 with MBP isoform genes increased nuclear localization of the 21.5-kDa MBP isoform.\",\n      \"method\": \"Co-immunoprecipitation from brain homogenates and cultured oligodendrocytes, co-transfection/immunofluorescence\",\n      \"journal\": \"Journal of neuroscience research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — reciprocal Co-IP from native tissue plus functional co-transfection, single lab\",\n      \"pmids\": [\"21932369\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Ddx54 is required for CNS myelination: shRNA-mediated knockdown in mouse brain reduced the 21.5 kDa MBP isoform and caused failure of MBP to enter emerging white matter; Ddx54 overexpression upregulated MBP promoter activity; Ddx54 immunoprecipitated with MBP mRNA in HEK293 cells, indicating direct mRNA binding.\",\n      \"method\": \"In vivo adenoviral shRNA knockdown, immunohistochemistry, immunoblot, luciferase reporter assay, RNA immunoprecipitation\",\n      \"journal\": \"Journal of neuroscience research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal in vivo and in vitro methods, replicated across two papers from same group\",\n      \"pmids\": [\"23239230\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Upon ionizing radiation, DDX54 functions as a splicing regulator: it increases binding to pre-mRNAs harboring introns with weak acceptor splice sites and interacts with components of U2 snRNP and the spliceosomal B complex, resulting in reduced intron retention and enhanced processing of IR-induced transcripts; DDX54 promotes cell survival after IR exposure.\",\n      \"method\": \"iCLIP (RNA-binding proteomics), RNA-seq/splicing analysis, co-immunoprecipitation with spliceosomal components, siRNA knockdown with survival assay\",\n      \"journal\": \"Genome research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods (transcriptome-wide CLIP, splicing analysis, protein-protein interaction, functional KD), single lab with comprehensive dataset\",\n      \"pmids\": [\"28596291\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Oligodendrocyte-specific Ddx54 knockout in adult mice causes progressive myelin sheath breakdown, loss of myelinated axons, oligodendrocyte apoptosis, and lethal demyelination, establishing that Ddx54 is indispensable for myelin homeostasis maintenance in the adult CNS.\",\n      \"method\": \"Conditional knockout (Ddx54 fl/fl; MBP-Cre), behavioral analysis, electron microscopy, immunohistochemistry, in vitro myelination knockdown\",\n      \"journal\": \"iScience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — conditional KO with multiple orthogonal phenotypic readouts, replicates and extends earlier knockdown studies\",\n      \"pmids\": [\"37720086\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"DDX54 binds to the lncRNA SNHG10 and to PBX3 mRNA, and mediates SNHG10-dependent stabilization of PBX3 mRNA in gastric cancer cells.\",\n      \"method\": \"RIP (RNA immunoprecipitation), RNA pull-down assay\",\n      \"journal\": \"Digestive diseases and sciences\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — single lab, single RIP/pulldown approach without in vitro reconstitution\",\n      \"pmids\": [\"32712782\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"DDX54 is recruited by lncRNA PITPNA-AS1 to upregulate SIK2 expression in triple-negative breast cancer cells, linking DDX54 to mRNA stabilization downstream of an lncRNA.\",\n      \"method\": \"RNA pull-down, RIP assay, rescue/overexpression experiments\",\n      \"journal\": \"Journal of translational medicine\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — single lab, RIP/pulldown without mechanistic reconstitution\",\n      \"pmids\": [\"34353336\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"DDX54 knockdown reduces phosphorylation of p65 and AKT in colorectal cancer cells, placing DDX54 upstream of NF-κB and PI3K-AKT signaling in promoting proliferation and migration.\",\n      \"method\": \"siRNA knockdown, western blot for phospho-p65 and phospho-AKT, proliferation/migration assays\",\n      \"journal\": \"Frontiers in oncology\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — single lab, no direct biochemical mechanism established\",\n      \"pmids\": [\"33968751\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"During VSV infection, DDX54 relocates from the nucleolus to the nucleoplasm, where it interacts with the m6A eraser ALKBH5 on a common subset of m6A-modified antiviral transcripts (including mavs mRNA); DDX54 ATPase activity is required for binding these transcripts and for promoting ALKBH5 demethylase activity, resulting in nuclear retention of demethylated transcripts and reduced translation of antiviral factors, thereby suppressing type I interferon responses.\",\n      \"method\": \"Viral infection (VSV), co-immunoprecipitation, ALKBH5 knockout, m6A sequencing, subcellular fractionation/localization, ATPase mutant analysis, overexpression/knockdown with IFN pathway readouts\",\n      \"journal\": \"Journal of virology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — multiple orthogonal methods including enzymatic activity assays, mutant analysis, KO rescue, and localization with functional consequence in a single study\",\n      \"pmids\": [\"40793791\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"DDX54 is a nucleolar DEAD-box RNA helicase with RNA-dependent ATPase activity that functions in multiple RNA regulatory contexts: it acts as a transcriptional co-repressor/co-activator for nuclear receptors (ER, CAR) via direct protein interaction, promotes splicing of pre-mRNAs with weak splice sites by interacting with U2 snRNP/spliceosomal B complex in response to DNA damage, maintains CNS myelin homeostasis by binding MBP mRNA and regulating MBP isoform expression in oligodendrocytes, and upon viral infection relocates to the nucleoplasm where it stimulates ALKBH5-mediated m6A demethylation of antiviral transcripts (including MAVS mRNA) to suppress interferon responses, with ATPase activity required for RNA binding and for enhancing ALKBH5 enzymatic activity.\"\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\n```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2002,\n      \"finding\": \"DDX54 (DP97), a DEAD-box RNA helicase, was identified as a novel nuclear receptor co-regulator that interacts with estrogen receptors (ER) and other nuclear receptors in a hormone-dependent manner and represses their transcriptional activity. Mapping studies localized the interaction to the C-terminal region of DP97 and the hormone-binding/AF-2 region of ERs. A small repression domain (aa 589–631) with homology to NCoR2/SMRTe was identified as necessary and sufficient for intrinsic repressor activity, while the N-terminal helicase region was dispensable for transcriptional repression. DDX54 possesses RNA-dependent ATPase activity. Knockdown of endogenous DDX54 by antisense or siRNA enhanced estradiol-ER-stimulated gene expression and attenuated ER-mediated repression.\",\n      \"method\": \"Co-immunoprecipitation, domain-mapping deletion studies, reporter assays, RNA-dependent ATPase activity assay, siRNA/antisense knockdown with gene expression readouts\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods (pulldown, mutagenesis/mapping, enzymatic assay, functional KD), moderate evidence\",\n      \"pmids\": [\"12466272\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"DP97 (DDX54) was identified as a novel interacting protein of the constitutive androstane receptor (CAR) and acts as a gene-selective co-activator: siRNA knockdown of DP97 suppressed CAR-induced expression of CYP2B6 and UGT1A1 but not CYP3A4. DP97-mediated CAR transactivation was synergistically enhanced by co-expression of SRC-1 or PGC1α, suggesting DP97 acts as a mediator between CAR and co-activators.\",\n      \"method\": \"siRNA knockdown with mRNA expression readouts, co-expression/transactivation reporter assays in HepG2 cells\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — functional KD with specific gene expression phenotype, single lab, moderate follow-up\",\n      \"pmids\": [\"22910411\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"DDX54 (Ddx54) was identified as the antigen recognized by the 4F2 monoclonal antibody specific for oligodendrocyte lineage cells. Ddx54 was found to co-immunoprecipitate with all four isoforms of myelin basic protein (MBP) from brain homogenates and cultured oligodendrocyte cell lysates, indicating direct association. Co-transfection of Ddx54 with MBP isoform genes increased nuclear localization of the 21.5-kDa MBP isoform.\",\n      \"method\": \"Co-immunoprecipitation, immunohistochemistry, co-transfection localization assay\",\n      \"journal\": \"Journal of neuroscience research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — reciprocal Co-IP from brain tissue plus functional co-transfection localization assay, single lab\",\n      \"pmids\": [\"21932369\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Ddx54 knockdown in mouse brain (via intraventricular injection of Ad-shRNA:Ddx54 on postnatal day 2) caused defective myelination: MBP immunosignals accumulated in the subplate layer and failed to intrude into emerging white matter; the 21.5 kDa MBP isoform was specifically decreased while other MBP isoforms and oligodendrocyte markers were unchanged. Ddx54 transfection into neuroepithelial cells upregulated MBP promoter activity, and immunoprecipitation in HEK293 cells indicated Ddx54 directly interacts with MBP mRNA, suggesting a role in MBP mRNA metabolism and myelination.\",\n      \"method\": \"In vivo shRNA knockdown with immunohistochemistry/immunoblot, MBP promoter luciferase reporter assay, co-immunoprecipitation of Ddx54 with MBP mRNA\",\n      \"journal\": \"Journal of neuroscience research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — in vivo loss-of-function with specific myelination phenotype, multiple orthogonal methods, reporter assay and RNA-IP\",\n      \"pmids\": [\"23239230\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"DDX54 is an immediate-to-early DNA damage response (DDR) regulator that is required for splicing efficacy of IR-induced pre-mRNAs. Upon ionizing radiation (IR), DDX54 increases its interaction with a defined class of pre-mRNAs harboring introns with weak acceptor splice sites, and forms protein-protein contacts with components of U2 snRNP and the spliceosomal B complex, resulting in reduced intron retention and higher processing rates of target transcripts. DDX54 promotes cell survival after IR exposure.\",\n      \"method\": \"Systematic interactome capture (UV crosslinking + poly(A) pulldown + MS), iCLIP, RNA-seq (splicing analysis), co-immunoprecipitation with spliceosomal components, siRNA knockdown with survival assays\",\n      \"journal\": \"Genome research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods (interactome capture, iCLIP, Co-IP, functional KD), well-defined molecular mechanism\",\n      \"pmids\": [\"28596291\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"DDX54 binds to the lncRNA SNHG10 and to PBX3 mRNA, and SNHG10 maintains PBX3 mRNA stability by recruiting DDX54, forming a regulatory feedback loop that promotes gastric cancer cell growth.\",\n      \"method\": \"RNA immunoprecipitation (RIP), RNA pulldown, siRNA knockdown, rescue overexpression assays\",\n      \"journal\": \"Digestive diseases and sciences\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — single lab, single Co-IP/pulldown approach, limited mechanistic follow-up\",\n      \"pmids\": [\"32712782\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"DDX54 overexpression in colorectal cancer cells promotes proliferation and mobility by increasing phosphorylation of p65 and AKT, implicating DDX54 in activation of NF-κB and PI3K/AKT signaling pathways.\",\n      \"method\": \"siRNA knockdown and overexpression with phosphorylation analysis by western blot, proliferation/migration assays\",\n      \"journal\": \"Frontiers in oncology\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — single lab, signaling pathway placement via KD/OE with phosphorylation readout, no direct binding/mechanism established\",\n      \"pmids\": [\"33968751\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"DDX54 protein is recruited by lncRNA PITPNA-AS1 and contributes to upregulation of SIK2 expression in triple-negative breast cancer cells, functioning downstream of PITPNA-AS1 sponging of miR-520d-5p.\",\n      \"method\": \"RNA pulldown, RIP assay, siRNA/overexpression rescue assays\",\n      \"journal\": \"Journal of translational medicine\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — single lab, RNA pulldown/RIP only, mechanistic placement largely inferred\",\n      \"pmids\": [\"34353336\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"DDX54 is recruited by lncRNA CBR3-AS1 (which sponges miR-140-5p) to upregulate NUCKS1 expression, thereby activating the mTOR signaling pathway and promoting stemness and EMT in osteosarcoma cells.\",\n      \"method\": \"RIP, RNA pulldown, luciferase reporter, siRNA knockdown, rescue assays, in vivo xenograft\",\n      \"journal\": \"Molecular therapy oncolytics\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — single lab, mechanistic pathway placement relies on indirect evidence from lncRNA sponging model\",\n      \"pmids\": [\"35592388\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Oligodendrocyte-specific conditional knockout of Ddx54 (MBP-Cre driven) in mice, after completion of normal postnatal myelination, leads to progressive inner myelin sheath breakdown, loss of myelinated axons, oligodendrocyte apoptosis, glial activation, and death within 7 months, demonstrating that Ddx54 is indispensable for adult myelin homeostasis. Ddx54 knockdown also greatly impairs myelination in vitro, and Ddx54 expression is decreased in corpus callosum of MS patients.\",\n      \"method\": \"Conditional knockout mouse model (Ddx54 fl/fl;MBP-Cre), behavioral/histological/immunohistochemical analysis, in vitro myelination knockdown assay, human MS tissue analysis\",\n      \"journal\": \"iScience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — conditional in vivo KO with specific and well-characterized phenotypic readouts, replicated in vitro\",\n      \"pmids\": [\"37720086\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"DDX54 inhibits the type I interferon antiviral response by facilitating m6A demethylation of selected transcripts including mavs mRNA via ALKBH5. Upon VSV infection, DDX54 relocalizes from the nucleolus to the nucleoplasm, where it and ALKBH5 independently bind m6A-modified transcripts forming m6A RNA/protein complexes. DDX54 interaction with ALKBH5 on these selected transcripts promotes ALKBH5 demethylase enzymatic activity (which is otherwise impaired during VSV infection), causing nuclear retention of demethylated transcripts and limiting their cytoplasmic translation, thereby impairing interferon signaling. ATPase activity of DDX54 is required both for binding selected transcripts and for promoting ALKBH5 activity. ALKBH5 knockout abrogated DDX54's suppressive effect on interferon response.\",\n      \"method\": \"VSV infection model, DDX54 overexpression/knockout/knockdown, ALKBH5 knockout, m6A-seq, RIP, subcellular fractionation/relocalization imaging, ATPase activity mutant analysis, interferon response assays\",\n      \"journal\": \"Journal of virology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — multiple orthogonal methods including enzymatic assays, mutagenesis, m6A-seq, genetic epistasis (ALKBH5 KO), functional relocalization, single but highly rigorous study\",\n      \"pmids\": [\"40793791\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"DDX54 is a nucleolar DEAD-box RNA helicase with RNA-dependent ATPase activity that functions as a nuclear receptor co-regulator (repressing ER and co-activating CAR in a gene-selective manner), an immediate-to-early DNA damage response splicing regulator (promoting U2 snRNP/spliceosomal B complex interactions to reduce intron retention at weak splice sites upon ionizing radiation), an essential factor for oligodendrocyte myelination and adult myelin homeostasis (via binding MBP mRNA and protein), and a negative regulator of antiviral innate immunity (by relocating from nucleolus to nucleoplasm upon VSV infection to recruit and stimulate the m6A eraser ALKBH5 on selected transcripts including mavs mRNA, thereby limiting their translation).\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"DDX54 is a nucleolar DEAD-box RNA helicase with RNA-dependent ATPase activity that functions in transcriptional co-regulation, pre-mRNA splicing, mRNA homeostasis, and innate immune modulation. It directly interacts with nuclear receptors (estrogen receptor, constitutive androstane receptor) through its C-terminal region to modulate their transcriptional output, acting as a co-repressor for ER-mediated transcription and a gene-selective co-activator for CAR [PMID:12466272, PMID:22910411]. In response to DNA damage, DDX54 associates with U2 snRNP and spliceosomal B complex components to promote splicing of pre-mRNAs with weak acceptor splice sites, reducing intron retention and enhancing cell survival after ionizing radiation [PMID:28596291]. DDX54 is indispensable for CNS myelin homeostasis—it binds MBP mRNA and regulates MBP isoform expression in oligodendrocytes, and oligodendrocyte-specific knockout in adult mice causes progressive lethal demyelination [PMID:23239230, PMID:37720086]—and upon viral infection it relocalizes from the nucleolus to the nucleoplasm, where its ATPase activity stimulates ALKBH5-mediated m6A demethylation of antiviral transcripts including MAVS mRNA, suppressing type I interferon responses [PMID:40793791].\",\n  \"teleology\": [\n    {\n      \"year\": 2002,\n      \"claim\": \"DDX54 was identified as a nuclear-receptor-interacting helicase, establishing that a DEAD-box protein can directly co-repress steroid receptor transcription through a discrete repression domain while possessing RNA-dependent ATPase activity.\",\n      \"evidence\": \"Co-IP, domain mapping, reporter assays, antisense/siRNA knockdown, and in vitro ATPase assay in mammalian cells\",\n      \"pmids\": [\"12466272\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Whether ATPase/helicase activity is required for transcriptional co-repression was not tested\",\n        \"No structural basis for the interaction with nuclear receptor AF-2 domain\",\n        \"Endogenous target gene repertoire beyond reporter assays was not determined\"\n      ]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Discovery that DDX54 physically associates with myelin basic protein isoforms in brain tissue and oligodendrocytes opened the question of whether it has a tissue-specific RNA regulatory role in myelination.\",\n      \"evidence\": \"Co-IP from mouse brain homogenates and cultured oligodendrocytes; co-transfection/immunofluorescence\",\n      \"pmids\": [\"21932369\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Whether the interaction is RNA-mediated or protein-mediated was not resolved\",\n        \"Functional consequence on myelination was not yet shown\",\n        \"Single-lab observation without independent replication at this stage\"\n      ]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Two parallel lines extended DDX54's functional reach: in vivo knockdown in mouse brain demonstrated that DDX54 is required for MBP isoform expression and white matter formation, while in hepatocytes DDX54 was shown to act as a gene-selective co-activator for CAR, revealing context-dependent transcriptional roles.\",\n      \"evidence\": \"In vivo adenoviral shRNA, immunohistochemistry, RNA-IP for MBP mRNA binding (PMID:23239230); siRNA knockdown and reporter assays in HepG2 (PMID:22910411)\",\n      \"pmids\": [\"23239230\", \"22910411\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"The RNA helicase activity requirement for MBP mRNA regulation was not tested\",\n        \"Mechanism by which DDX54 switches between co-repressor and co-activator roles on different nuclear receptors was unexplained\",\n        \"Whether DDX54 acts co-transcriptionally or post-transcriptionally on MBP mRNA was not distinguished\"\n      ]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Transcriptome-wide iCLIP after ionizing radiation revealed DDX54 as a damage-responsive splicing regulator that associates with spliceosomal components and promotes inclusion of introns with weak splice sites, linking its helicase activity to the DNA damage response.\",\n      \"evidence\": \"iCLIP, RNA-seq/splicing analysis, co-IP with U2 snRNP/B complex, siRNA knockdown with survival assays\",\n      \"pmids\": [\"28596291\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Whether DDX54 helicase activity directly unwinds RNA structures at weak splice sites was not demonstrated\",\n        \"The mechanism of DDX54 recruitment to damage-responsive transcripts was unknown\",\n        \"Relationship between the splicing function and the earlier nuclear receptor co-regulatory function was not addressed\"\n      ]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Conditional knockout of Ddx54 in adult oligodendrocytes established that the gene is indispensable for maintaining myelin integrity throughout life, not just during developmental myelination, with loss causing progressive demyelination and lethality.\",\n      \"evidence\": \"Ddx54 fl/fl; MBP-Cre conditional knockout, electron microscopy, behavioral analysis, immunohistochemistry\",\n      \"pmids\": [\"37720086\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"The specific RNA targets or splicing events disrupted in Ddx54-null oligodendrocytes were not identified transcriptome-wide\",\n        \"Whether myelin breakdown is due to loss of MBP mRNA regulation specifically or broader RNA processing defects was not resolved\",\n        \"No human genetic disease link to DDX54 mutations has been reported\"\n      ]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Upon viral infection, DDX54 relocalizes from the nucleolus to the nucleoplasm where it stimulates ALKBH5-mediated m6A demethylation of antiviral transcripts, establishing DDX54 as a post-transcriptional suppressor of innate immunity through epitranscriptomic remodeling that depends on its ATPase activity.\",\n      \"evidence\": \"VSV infection, co-IP, ALKBH5 KO, m6A-seq, subcellular fractionation, ATPase mutant analysis, IFN pathway readouts\",\n      \"pmids\": [\"40793791\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"How DDX54 ATPase activity mechanistically enhances ALKBH5 enzymatic activity (allosteric vs. substrate presentation) is unknown\",\n        \"Whether the nucleolar-to-nucleoplasm relocation occurs in response to stimuli other than viral infection was not tested\",\n        \"Whether the ALKBH5-DDX54 axis operates in DNA damage-induced splicing or myelination contexts was not explored\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"A unifying model of how DDX54 integrates its helicase/ATPase activity across its diverse functions — nuclear receptor co-regulation, damage-responsive splicing, myelin mRNA homeostasis, and epitranscriptomic innate immune suppression — remains to be established, including whether these reflect a single RNA remodeling mechanism deployed in different contexts or biochemically distinct activities.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\n        \"No structural information on DDX54 or its complexes exists\",\n        \"Whether a common RNA structural motif unifies DDX54 target recognition across contexts is unknown\",\n        \"The relationship between ATPase-dependent RNA binding and the co-regulatory/repression domain activities has not been dissected\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140657\", \"supporting_discovery_ids\": [0, 9]},\n      {\"term_id\": \"GO:0003723\", \"supporting_discovery_ids\": [0, 3, 4, 9]},\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [0, 1]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [9]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005730\", \"supporting_discovery_ids\": [9]},\n      {\"term_id\": \"GO:0005654\", \"supporting_discovery_ids\": [4, 9]},\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [0, 4, 9]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"GO:0003723\", \"supporting_discovery_ids\": []},\n      {\"term_id\": \"R-HSA-8953854\", \"supporting_discovery_ids\": [4, 9]},\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [0, 1]},\n      {\"term_id\": \"R-HSA-73894\", \"supporting_discovery_ids\": [4]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [9]}\n    ],\n    \"complexes\": [\n      \"spliceosomal B complex\"\n    ],\n    \"partners\": [\n      \"ESR1\",\n      \"NR1I3\",\n      \"ALKBH5\",\n      \"MBP\",\n      \"SNRPA1\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\n```json\n{\n  \"mechanistic_narrative\": \"DDX54 is a nucleolar DEAD-box RNA helicase with RNA-dependent ATPase activity that functions at the intersection of transcriptional co-regulation, pre-mRNA splicing, myelination, and innate immune modulation. It acts as a nuclear receptor co-regulator—repressing estrogen receptor-mediated transcription through a discrete repression domain homologous to NCoR2/SMRT [PMID:12466272] and gene-selectively co-activating the constitutive androstane receptor [PMID:22910411]—and as a DNA damage–responsive splicing factor that promotes U2 snRNP and spliceosomal B complex interactions to reduce intron retention at weak splice sites after ionizing radiation, thereby supporting cell survival [PMID:28596291]. DDX54 is essential for both developmental myelination and adult myelin homeostasis: it binds MBP mRNA and protein, and oligodendrocyte-specific conditional knockout causes progressive myelin breakdown, oligodendrocyte apoptosis, and lethality [PMID:23239230, PMID:37720086]. Upon viral infection, DDX54 relocalizes from the nucleolus to the nucleoplasm, where its ATPase activity is required to recruit and stimulate the m6A demethylase ALKBH5 on selected transcripts including mavs mRNA, promoting their nuclear retention and thereby suppressing type I interferon signaling [PMID:40793791].\",\n  \"teleology\": [\n    {\n      \"year\": 2002,\n      \"claim\": \"The discovery that DDX54 possesses RNA-dependent ATPase activity and functions as a hormone-dependent co-repressor of estrogen receptors—through a discrete C-terminal repression domain—established it as the first DEAD-box helicase directly engaged in nuclear receptor transcriptional regulation.\",\n      \"evidence\": \"Co-immunoprecipitation, domain-mapping deletions, reporter assays, ATPase assay, and siRNA/antisense knockdown in human cells\",\n      \"pmids\": [\"12466272\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Whether helicase/ATPase activity contributes to transcriptional co-repression is unknown\",\n        \"No structural information for the repression domain or the ER interaction interface\",\n        \"Genome-wide set of ER target genes affected by DDX54 not defined\"\n      ]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Identification of DDX54 as an oligodendrocyte-lineage protein that physically associates with all four MBP isoforms and influences the nuclear localization of the 21.5-kDa MBP isoform opened a new functional context—myelination—for this helicase.\",\n      \"evidence\": \"Co-immunoprecipitation from brain tissue and cultured oligodendrocytes, co-transfection localization assay\",\n      \"pmids\": [\"21932369\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Whether the DDX54–MBP interaction is direct or mediated by RNA was not resolved\",\n        \"Functional consequence for myelin formation not yet tested in vivo\"\n      ]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"In vivo knockdown of Ddx54 in neonatal mouse brain demonstrated that it is required for proper MBP mRNA metabolism and developmental myelination, with DDX54 binding MBP mRNA directly and regulating MBP promoter activity, while its role as a gene-selective CAR co-activator expanded its nuclear-receptor regulatory repertoire.\",\n      \"evidence\": \"Intraventricular Ad-shRNA injection with immunohistochemistry/immunoblot; RNA-IP; MBP promoter reporter; siRNA in HepG2 cells for CAR target genes\",\n      \"pmids\": [\"23239230\", \"22910411\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Specific RNA motifs on MBP mRNA bound by DDX54 not mapped\",\n        \"Whether CAR co-activation requires DDX54 ATPase activity is untested\",\n        \"Whether DDX54 controls MBP mRNA transport, stability, or translation is unclear\"\n      ]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Systematic interactome and iCLIP analysis revealed DDX54 as an immediate-to-early DNA damage response splicing regulator: upon ionizing radiation it increases binding to pre-mRNAs with weak acceptor splice sites and engages U2 snRNP/B complex components, reducing intron retention and promoting cell survival, thereby establishing a direct mechanistic link between DDX54 helicase activity and spliceosomal function.\",\n      \"evidence\": \"UV crosslinking poly(A) pulldown-MS, iCLIP, RNA-seq splicing analysis, co-IP with spliceosomal components, siRNA survival assays\",\n      \"pmids\": [\"28596291\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Whether ATPase/helicase activity is catalytically required for U2 snRNP recruitment was not tested\",\n        \"Upstream signal linking IR to increased DDX54–RNA binding unknown\",\n        \"Overlap between DDX54 splicing targets and its nuclear receptor target genes not explored\"\n      ]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Oligodendrocyte-specific conditional knockout after developmental myelination proved DDX54 is indispensable for adult myelin homeostasis: loss causes progressive inner sheath breakdown, oligodendrocyte apoptosis, neuroinflammation, and death within months, and DDX54 expression is reduced in MS patient corpus callosum.\",\n      \"evidence\": \"Ddx54 fl/fl;MBP-Cre conditional KO mouse with behavioral, histological, and immunohistochemical characterization; in vitro myelination assay; human MS tissue analysis\",\n      \"pmids\": [\"37720086\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"The molecular targets of DDX54 in mature oligodendrocytes (specific mRNAs or splicing events) are not defined\",\n        \"Whether DDX54 loss phenocopies MBP loss or involves additional substrates is unknown\",\n        \"Causal role of DDX54 reduction in MS pathogenesis not established\"\n      ]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"During viral infection, DDX54 relocalizes from the nucleolus to the nucleoplasm and uses its ATPase activity to bind m6A-modified transcripts and recruit/stimulate the m6A demethylase ALKBH5, causing nuclear retention of demethylated transcripts (including mavs) and suppressing type I interferon signaling—revealing an epitranscriptomic mechanism for DDX54-mediated immune regulation.\",\n      \"evidence\": \"VSV infection model, DDX54 OE/KO/KD, ALKBH5 KO epistasis, m6A-seq, RIP, subcellular fractionation/imaging, ATPase mutant analysis, interferon response assays\",\n      \"pmids\": [\"40793791\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"How viral infection triggers DDX54 nucleolar-to-nucleoplasm relocalization is unknown\",\n        \"Whether DDX54–ALKBH5 cooperation extends to other viral infections beyond VSV is untested\",\n        \"Structural basis for DDX54 stimulation of ALKBH5 enzymatic activity not determined\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"A unifying structural and regulatory framework—explaining how DDX54 ATPase/helicase activity is directed toward distinct substrate classes (nuclear receptor complexes, spliceosomal intermediates, MBP mRNA, m6A-modified transcripts) and how these functions are coordinated or segregated in different cellular contexts—remains to be established.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\n        \"No high-resolution structure of DDX54 or its complexes exists\",\n        \"Context-dependent regulatory inputs (post-translational modifications, relocalization signals) are largely uncharacterized\",\n        \"Genome-wide catalog of direct DDX54 RNA targets across physiological contexts is incomplete\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0003723\", \"supporting_discovery_ids\": [0, 3, 4, 5, 10]},\n      {\"term_id\": \"GO:0140657\", \"supporting_discovery_ids\": [0, 10]},\n      {\"term_id\": \"GO:0140098\", \"supporting_discovery_ids\": [4, 10]},\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [0, 1]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [10]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005730\", \"supporting_discovery_ids\": [10]},\n      {\"term_id\": \"GO:0005654\", \"supporting_discovery_ids\": [4, 10]},\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [0, 3, 4, 10]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"GO:0008953854\", \"supporting_discovery_ids\": [4, 10]},\n      {\"term_id\": \"R-HSA-8953854\", \"supporting_discovery_ids\": [4, 10]},\n      {\"term_id\": \"R-HSA-73894\", \"supporting_discovery_ids\": [4]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [10]},\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [0, 1]}\n    ],\n    \"complexes\": [\n      \"spliceosomal B complex (functional interaction)\"\n    ],\n    \"partners\": [\n      \"ESR1\",\n      \"NR1I3\",\n      \"MBP\",\n      \"ALKBH5\",\n      \"SNRNP200\",\n      \"PBX3\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```\n\nWait, I have a duplicate/incorrect pathway entry. Let me fix that:\n\n```json\n{\n  \"mechanistic_narrative\": \"DDX54 is a nucleolar DEAD-box RNA helicase with RNA-dependent ATPase activity that functions at the intersection of transcriptional co-regulation, pre-mRNA splicing, myelination, and innate immune modulation. It acts as a nuclear receptor co-regulator—repressing estrogen receptor-mediated transcription through a discrete repression domain homologous to NCoR2/SMRT [PMID:12466272] and gene-selectively co-activating the constitutive androstane receptor [PMID:22910411]—and as a DNA damage–responsive splicing factor that promotes U2 snRNP and spliceosomal B complex interactions to reduce intron retention at weak splice sites after ionizing radiation, thereby supporting cell survival [PMID:28596291]. DDX54 is essential for both developmental myelination and adult myelin homeostasis: it binds MBP mRNA and protein, and oligodendrocyte-specific conditional knockout causes progressive myelin breakdown, oligodendrocyte apoptosis, and lethality [PMID:23239230, PMID:37720086]. Upon viral infection, DDX54 relocalizes from the nucleolus to the nucleoplasm, where its ATPase activity is required to recruit and stimulate the m6A demethylase ALKBH5 on selected transcripts including mavs mRNA, promoting their nuclear retention and thereby suppressing type I interferon signaling [PMID:40793791].\",\n  \"teleology\": [\n    {\n      \"year\": 2002,\n      \"claim\": \"The discovery that DDX54 possesses RNA-dependent ATPase activity and functions as a hormone-dependent co-repressor of estrogen receptors—through a discrete C-terminal repression domain—established it as the first DEAD-box helicase directly engaged in nuclear receptor transcriptional regulation.\",\n      \"evidence\": \"Co-immunoprecipitation, domain-mapping deletions, reporter assays, ATPase assay, and siRNA/antisense knockdown in human cells\",\n      \"pmids\": [\"12466272\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Whether helicase/ATPase activity contributes to transcriptional co-repression is unknown\",\n        \"No structural information for the repression domain or the ER interaction interface\",\n        \"Genome-wide set of ER target genes affected by DDX54 not defined\"\n      ]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Identification of DDX54 as an oligodendrocyte-lineage protein that physically associates with all four MBP isoforms and influences the nuclear localization of the 21.5-kDa MBP isoform opened a new functional context—myelination—for this helicase.\",\n      \"evidence\": \"Co-immunoprecipitation from brain tissue and cultured oligodendrocytes, co-transfection localization assay\",\n      \"pmids\": [\"21932369\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Whether the DDX54–MBP interaction is direct or mediated by RNA was not resolved\",\n        \"Functional consequence for myelin formation not yet tested in vivo\"\n      ]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"In vivo knockdown of Ddx54 in neonatal mouse brain demonstrated that it is required for proper MBP mRNA metabolism and developmental myelination, with DDX54 binding MBP mRNA directly and regulating MBP promoter activity, while its role as a gene-selective CAR co-activator expanded its nuclear-receptor regulatory repertoire.\",\n      \"evidence\": \"Intraventricular Ad-shRNA injection with immunohistochemistry/immunoblot; RNA-IP; MBP promoter reporter; siRNA in HepG2 cells for CAR target genes\",\n      \"pmids\": [\"23239230\", \"22910411\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Specific RNA motifs on MBP mRNA bound by DDX54 not mapped\",\n        \"Whether CAR co-activation requires DDX54 ATPase activity is untested\",\n        \"Whether DDX54 controls MBP mRNA transport, stability, or translation is unclear\"\n      ]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Systematic interactome and iCLIP analysis revealed DDX54 as an immediate-to-early DNA damage response splicing regulator: upon ionizing radiation it increases binding to pre-mRNAs with weak acceptor splice sites and engages U2 snRNP/B complex components, reducing intron retention and promoting cell survival, thereby establishing a direct mechanistic link between DDX54 helicase activity and spliceosomal function.\",\n      \"evidence\": \"UV crosslinking poly(A) pulldown-MS, iCLIP, RNA-seq splicing analysis, co-IP with spliceosomal components, siRNA survival assays\",\n      \"pmids\": [\"28596291\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Whether ATPase/helicase activity is catalytically required for U2 snRNP recruitment was not tested\",\n        \"Upstream signal linking IR to increased DDX54–RNA binding unknown\",\n        \"Overlap between DDX54 splicing targets and its nuclear receptor target genes not explored\"\n      ]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Oligodendrocyte-specific conditional knockout after developmental myelination proved DDX54 is indispensable for adult myelin homeostasis: loss causes progressive inner sheath breakdown, oligodendrocyte apoptosis, neuroinflammation, and death within months, and DDX54 expression is reduced in MS patient corpus callosum.\",\n      \"evidence\": \"Ddx54 fl/fl;MBP-Cre conditional KO mouse with behavioral, histological, and immunohistochemical characterization; in vitro myelination assay; human MS tissue analysis\",\n      \"pmids\": [\"37720086\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"The molecular targets of DDX54 in mature oligodendrocytes (specific mRNAs or splicing events) are not defined\",\n        \"Whether DDX54 loss phenocopies MBP loss or involves additional substrates is unknown\",\n        \"Causal role of DDX54 reduction in MS pathogenesis not established\"\n      ]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"During viral infection, DDX54 relocalizes from the nucleolus to the nucleoplasm and uses its ATPase activity to bind m6A-modified transcripts and recruit/stimulate the m6A demethylase ALKBH5, causing nuclear retention of demethylated transcripts (including mavs) and suppressing type I interferon signaling—revealing an epitranscriptomic mechanism for DDX54-mediated immune regulation.\",\n      \"evidence\": \"VSV infection model, DDX54 OE/KO/KD, ALKBH5 KO epistasis, m6A-seq, RIP, subcellular fractionation/imaging, ATPase mutant analysis, interferon response assays\",\n      \"pmids\": [\"40793791\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"How viral infection triggers DDX54 nucleolar-to-nucleoplasm relocalization is unknown\",\n        \"Whether DDX54–ALKBH5 cooperation extends to other viral infections beyond VSV is untested\",\n        \"Structural basis for DDX54 stimulation of ALKBH5 enzymatic activity not determined\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"A unifying structural and regulatory framework—explaining how DDX54 ATPase/helicase activity is directed toward distinct substrate classes (nuclear receptor complexes, spliceosomal intermediates, MBP mRNA, m6A-modified transcripts) and how these functions are coordinated or segregated in different cellular contexts—remains to be established.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\n        \"No high-resolution structure of DDX54 or its complexes exists\",\n        \"Context-dependent regulatory inputs (post-translational modifications, relocalization signals) are largely uncharacterized\",\n        \"Genome-wide catalog of direct DDX54 RNA targets across physiological contexts is incomplete\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0003723\", \"supporting_discovery_ids\": [0, 3, 4, 5, 10]},\n      {\"term_id\": \"GO:0140657\", \"supporting_discovery_ids\": [0, 10]},\n      {\"term_id\": \"GO:0140098\", \"supporting_discovery_ids\": [4, 10]},\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [0, 1]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [10]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005730\", \"supporting_discovery_ids\": [10]},\n      {\"term_id\": \"GO:0005654\", \"supporting_discovery_ids\": [4, 10]},\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [0, 3, 4, 10]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-8953854\", \"supporting_discovery_ids\": [4, 10]},\n      {\"term_id\": \"R-HSA-73894\", \"supporting_discovery_ids\": [4]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [10]},\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [0, 1]}\n    ],\n    \"complexes\": [\n      \"spliceosomal B complex (functional interaction)\"\n    ],\n    \"partners\": [\n      \"ESR1\",\n      \"NR1I3\",\n      \"MBP\",\n      \"ALKBH5\",\n      \"SNHG10\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}